[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 6 - The Spring Supplement of Shefaye Khatam 1 - ::
Shefaye Khatam 2018, 6 - The Spring Supplement of Shefaye Khatam 1 -: 154-154 Back to browse issues page
P123: Stimulating In Vivo Remyelination (IVR): A New Approach for Multiple Sclerosis Treatment
Saman Esmaeilnejad *, Sepideh Mansoori Majoofardi
Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran , saman.esmaeilnejad@gmail.com
Abstract:   (1112 Views)
Multiple sclerosis (MS) is one of the most common neuroinflammatory disorders that causes disability in the young adults. In this disease immune-driven demyelination and following that inefficient remyelination occurs. Therapies for this disease are limited, especially those to enhance myelin repair. Cellular reprogramming using defined genetic factors is a way to produce remyelinating Oligodendrocyte Precursor Cells (OPCs). These cells can be differentiated to Oligodendrocytes (OLs) to produce myelin sheets around naked axons. There are some theories indicating this approach has significant risks with respect to abnormal expression and genetic mutations. Therefore, researchers have focused on cell reprogramming by non-viral and non-integrating compounds. Recently, Proteins-mediated in vivo reprogramming and small molecules effective on neural cell reprogramming and transdifferentiation have attracted wide attention in the scientific community. There are several studies that have reported successful efforts of reprogramming neural cells and differentiation of this cells to the desired neural ones including OPCs and eventually OLs. In this article the authors will review recent studies that have been published in this research area. Recently, IVR is attracting attention of translational researchers aiming for medical applications. There are several studies that used IVR approach to induce regeneration in the central nervous system that indicates the growing attention to this research area. Despite challenges ahead, we hope that efforts of this growing research area will solve the problems ahead and some day may apply these therapeutic approach for treatment of MS patients
Keywords: IVR, Multiple Sclerosis, OPCs
Full-Text [PDF 240 kb]   (248 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Esmaeilnejad S, Mansoori Majoofardi S. P123: Stimulating In Vivo Remyelination (IVR): A New Approach for Multiple Sclerosis Treatment. Shefaye Khatam. 2018; 6 (S1) :154-154
URL: http://shefayekhatam.ir/article-1-1587-en.html


Volume 6 - The Spring Supplement of Shefaye Khatam 1 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4227